OVERVIEW

2024 Annual Symposium for Evolving Therapies and Drug Development in Oncology is organized by Inova Health System and will be held from Sep 27 - 28, 2024 at Inova Center for Personalized Health, Fairfax, Virginia, United States of America.

Description:
This two-day conference aimed at improving the knowledge and competence of academic and community oncology providers involved in Early Phase Clinical Trial Development and Management, Phase I/II Clinical Trials Conduct, and Management of Assessments and Safety Parameters involves more than the development of Concepts.

Recent Phase I Studies involving biomarker-guided design in the era of novel therapies has special challenges in selection of studies, patients’ enrollment along with networking with the surrounding institutions to ensure equity and inclusion of patients enrolled in the early phase studies that direct future drug development.

The activity will use a mix of didactic lectures and panel discussions to highlight various aspects of Early Phase Clinical Studies, Precision oncology, and addressing current challenges and opportunities in designing clinical trials in the era of novel therapies.

Learning Objectives:

  • Review challenges and trends in early drug development in the era of novel therapies.
  • Outline the best practices for the conduct of Phase I/II clinical trials in the era of novel therapies.
  • Identify phase I clinical trials to match patients’ needs.
  • Review the challenges and potential solutions for the diverse representation during drug development.

KEY DATES

Event Start Date
27 Sep, 2024
Event Start Date
Event End Date
28 Sep, 2024
Event End Date
Credits

Inova CME Accreditation:
The Medical Society of Virginia is a member of the Southern States CME Collaborative, an ACCME Recognized Accreditor. Inova Health System Office of Continuing Medical Education is accredited by the Southern States CME Collaborative to provide continuing medical education for physicians.

Credit Designation:
The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 16.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 16.5 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.

Nurse Credentialing FAQs:
For the purpose of recertification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME.

Available Credit:
16.50 AMA PRA Category 1 Credit™

  • 16.5 AMA PRA Category 1 Credits™
  • 16.5 Credits
  • TARGET AUDIENCE

    PhysicianNursingPharmacistStudentsRadiologistsResidentsGenetic counselorsFamily MedicineNursesInternistDietitianAllied Health ProfessionalsFellowsRadiation OncologistsMedical OncologistsTraineesAdvanced Practice Providers

    SPECIALITIES

    Oncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationInova Center for Personalized Health
    8100 Innovation Park Dr

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235